Forge Biologics Raises $90M in Series C Financing Posted on September 27, 2022 […] Read More… from Forge Biologics Raises $90M in Series C Financing
Acelyrin’s $300M haul for novel biologic leads a slate of biotech financings Posted on September 27, 2022 […] Read More… from Acelyrin’s $300M haul for novel biologic leads a slate of biotech financings
The Week’s 10 Biggest Funding Rounds Posted on September 19, 2022 […] Read More… from The Week’s 10 Biggest Funding Rounds
Forge Biologics announces $90 million Series C financing Posted on September 16, 2022 […] Read More… from Forge Biologics announces $90 million Series C financing
Venture Capital Deals – Forge Biologics… raised $90m in Series C funding co-led by Drive Capital and Aisling Capital Posted on September 16, 2022 (September 16, 2022) […] Read More… from Venture Capital Deals – Forge Biologics… raised $90m in Series C funding co-led by Drive Capital and Aisling Capital
Forge Bio bags $90m funding to expand CGT capabilities Posted on September 16, 2022 (September 16, 2022) […] Read More… from Forge Bio bags $90m funding to expand CGT capabilities
Forge Biologics brings in $90M Posted on September 16, 2022 […] Read More… from Forge Biologics brings in $90M
Forge Biologics Announces $90 Million Series C Financing to Expand Client Offerings and Add Services to Enhance End-to-End Gene Therapy Manufacturing Platforms Posted on September 16, 2022 […] Read More… from Forge Biologics Announces $90 Million Series C Financing to Expand Client Offerings and Add Services to Enhance End-to-End Gene Therapy Manufacturing Platforms
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO Posted on September 15, 2022 (September 15, 2022) […] Read More… from Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
